@ajchgt Profile picture

Dr. Kihn

@ajchgt

Oncologist & Researcher 🇬🇹🇨🇳 Former Editorial Fellow @asco_pubs JCO GO Passion for #HealthDisparities #BreastCancer #LiverCancer

Similar User
LudaBazhenovaMD photo

@LudaBazhenovaMD

Dr Joshua Walinjom photo

@walinjom

Ivy Riano, M.D. photo

@IvyLorena_Md

Nitin Jain photo

@NitinJainMD

Ramila photo

@RamilaShilpakar

Umang Swami photo

@umangtalking

GrepMed photo

@grepmeded

Manu photo

@manupandey27

I.M. Matters from ACP photo

@IMMattersACP

Miguel Perales M.D. photo

@DrMiguelPerales

Amanda Narod photo

@AmandaBinDC

Camila Braganca Xavier photo

@CamilaBragancaX

Nicolas Sayegh, MD photo

@nsayeghmd

Uqba Khan photo

@UqbaKhan

Lori Rosenstein, MD photo

@rosensteinl

Dr. Kihn Reposted

#ASCO25 is the place to be heard! Now accepting abstracts until Jan. 28. This is your chance to share your scientific discoveries on the largest global oncology stage. View submission resources & submit today: conferences.asco.org/am/abstract-su…


Best of ABC7 Meeting Latam. Esta sesión destacará los puntos del 7th Advanced Breast Cancer (ABC7) Global Alliance, adaptados al contexto de América Latina. Registro: lnkd.in/e_eQjEjf

Tweet Image 1

Dr. Kihn Reposted

Loved being a part of this piece for @CancerTodayMag Understanding patient preferences is so important when we offer therapies with marginal gains! #gerionc @CUCancerCenter

New treatments for breast cancer bring new decisions for patients. Understand the choices and how to filter the noise to make an informed decision. bit.ly/40pjCDp @natalie_sly @EnriqueSoto8 @mcpoliti #breastcancerawarenessmonth #bcsm

Tweet Image 1


Dr. Kihn Reposted

We’re pleased to announce that Dr. Katherine Van Loon has been named the new editor-in-chief of #JCOGO with her five-year term beginning February 1, 2025: brnw.ch/21wOcx0 @kvanloonmd @UCSF

Tweet Image 1

Dr. Kihn Reposted

Academic ironies

Tweet Image 1

Great reflections on universal health coverage for cancer

Tweet Image 1

Dr. Kihn Reposted

The YY Study grants 2024 are open in 2 days! The grants enable individuals from any country to carry out cancer research projects abroad. Don't miss this opportunity to advance cancer research through international collaboration! uicc.org/what-we-do/mem…

Tweet Image 1

Dr. Kihn Reposted

If you haven't voted in the @SIOGorg elections, you still have time to do it!!!! 🗳️🗳️🗳️🗳️🗳️🗳️🗳️🗳️🗳️🗳️🗳️🗳️ #gerionc #hemonc #globonc

If you are a @SIOGorg member, voting starts today for the SIOG Board of Directors Elections!!! I'm running for a seat and looking forward to working with all of you to make our society stronger. Vote from your SIOG profile or the email you received!!! #gerionc #hemonc

Tweet Image 1


Dr. Kihn Reposted

Performance of Low-Dose #Immunotherapy and Standard-Dose Immunotherapy in Microsatellite-Instability-High Metastatic Colorectal Cancer: Real World Data (CLouD High Study) brnw.ch/21wLZ56 @AnantRamaswamy


Dr. Kihn Reposted

Interesting and hypothesis provoking research letter in @JAMAOnc with checking it out. As an editor is a true honor to learn from others and see their efforts to improve care.

Radiation therapy followed by intrathecal trastuzumab and pertuzumab for HER2+ breast leptomeningeal disease is safe with initial intracranial control results that appear encouraging. ja.ma/4fAaPDY @KAhmedMD @MoffittNews

Tweet Image 1


Good things are coming...

Tweet Image 1

Dr. Kihn Reposted

Shape the future of global oncology! Nominate or express interest in the Editor-in-Chief role for JCO Global Oncology. Help advance cancer care and research in resource-limited settings. Make a difference today. ➡️ brnw.ch/21wKT3V


Dr. Kihn Reposted

🤔 Think you have what it takes to be the next Editor in Chief of JCO Global Oncology? Know someone who does? Use this form to nominate yourself or a peer. app.smartsheet.com/b/form/54ea927…


I don't even live in the US 🤔

Tweet Image 1

#ASCO24 Meeting them after almost a decade of the three of us becoming physicians. Oncology got us together 😊 Congratulations on your achievements.

Tweet Image 1

Dr. Kihn Reposted

Most pts (68%) with #Her2low #MBC had #financialToxicity, although this is not unique to tx with T-DXd Enhertu. Of the hundreds who received T-DXd, however, most did not receive it for more than 6 mo. Proud of Dr @KaitlynLapen for focusing on this overlooked group for #ASCO24

Tweet Image 1

Dr. Kihn Reposted

🗣️Excited to share our research on patient-provider communication at #ASCO24. Our research finds that although most with #breastcancer say communication was good overall, less than 1/3 felt that long term #bcsm side effects were explained. Let's talk about why this MATTERS. 🧵1/

Tweet Image 1

The use of Car Therapy in HCC, promising results, great for patients, a great challenge ahead to implement in LMICs, but still looking forward for future results in this area. #asco2024 #hcc

Tweet Image 1

Dr. Kihn Reposted

The highlight of my day! Reconnecting with two Guatemalan’s friends and colleagues at #ASCO24 🇬🇹

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.